Kara Maxwell, MD, Oncology, Philadelphia, PA, Hospital of the University of Pennsylvania

KaraNoelleMaxwellMDPHD

Oncology Philadelphia, PA

Hematologic Oncology

Assistant Professor

Dr. Maxwell is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Maxwell's full profile

Already have an account?

  • Office

    3400 Civic Center Blvd
    PCAM South 10th Floor, c/o Sierra Paylor
    Philadelphia, PA 19104
    Phone(215) 615-3341
    Fax(215) 662-4300
  • Is this information wrong?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFELLOWSHIP
  • New York Presbyterian Hospital -  Columbia Campus
    New York Presbyterian Hospital - Columbia CampusRESIDENCY
  • Weill Cornell Medical College of Cornell University
    Weill Cornell Medical College of Cornell UniversityMEDICAL_SCHOOL
  • Rockefeller UniversityOTHER_TRAINING
  • University of Wisconsin-MadisonOTHER_TRAINING

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2011 - 2020
  • NY State Medical License
    NY State Medical License 2008 - Present
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Career Award for Medical Scientists Burroughs Wellcome, 2017
  • Young Investigator Award Conquer Cancer Foundation of ASCO, 2015
  • Scholar in Training Award AACR, 2014
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Electronic health record phenotypes for precision medicine: perspectives and caveats from treatment of breast cancer at a single institution  
    Breitenstein MK, Liu H, Maxwell KN, Pathak J, Zhang R, Clinical and Translational Science, 1/1/2018
  • The differential diagnosis of a TP53 genetic testing result  
    MacFarland SP, Maxwell KN, Genetics in Medicine, 1/1/2018
  • BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers  
    Maxwell KN, Wubbenhorst B, Wenz BM, De Sloover D, Pluta J, Emery L, Barrett A, Kraya AA, Anastopoulos IN, Yu S, Jiang Y, Chen H, Zhang NR, Hackman N, D'Andrea K, Daber..., Nature Communications, 1/1/2017
  • Join now to see all

Abstracts/Posters

  • Genes Everywhere: Germline, Somatic, and Circulation
    Maxwell KN, Cancer Prevention, Genetics and Epidemiology Track at the American Society of Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2017
  • Moving Beyond Clinical Risk Prediction Models for Cancer Susceptibility Assessment - Unexpected Results with Multiplex Panel Testing
    Maxwell KN, Clinical Sciences Symposium, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2016
  • Evidence for diverse mechanisms of tumorigenesis in breast and ovarian tumors of BRCA1/2 carriers
    Maxwell, K.N., DeSloover D., Wubbenhorst, B., Wenz, B., Lunceford, N., Emery, L., D'Andrea, K., Feldman, M., Daber, R., Domchek, S.M., Nathanson, K.L., Cancer Research, 1/1/2015
  • Join now to see all

Lectures

  • Inherited mutations in breast cancer patients with and without multiple primary cancers. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
  • Inherited Genetics in Breast and Ovarian Tumorigenesis and Treatment 
    Multiple Dates and Locations - 1/1/2018
  • New challenges in germline cancer risk evaluation - the interaction with advancing tumor testing technologies 
    Chicago, IL - 1/1/2017
  • Join now to see all

Press Mentions

  • When Pancreatic Cancer Runs in the Family: Danielle’s Genetic Testing Journey
    When Pancreatic Cancer Runs in the Family: Danielle’s Genetic Testing JourneyFebruary 28, 2019
  • Beyond BRCA: Links Between Breast, Second Primary Cancer and Inherited Mutations
    Beyond BRCA: Links Between Breast, Second Primary Cancer and Inherited MutationsMay 31, 2018
  • Penn Study Finds Relationship Between PTEN Loss, Potential for Immune Response in BRCA 1/2-Deficient Ovarian Cancer
    Penn Study Finds Relationship Between PTEN Loss, Potential for Immune Response in BRCA 1/2-Deficient Ovarian CancerApril 15, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations